These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21516767)
1. [Pathogenetic aspects of arterial hypertension in metabolic syndrome]. Simonenko VB; Medvedev IN; Tolmachev VV Klin Med (Mosk); 2011; 89(1):49-51. PubMed ID: 21516767 [TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension in metabolic syndrome: pathophysiological aspects]. Gurgenian SV; Vatinian SKh; Zelveian PA Ter Arkh; 2014; 86(8):128-32. PubMed ID: 25306760 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome as a predictor of cardiovascular risk in children and adolescents. Flynn JT Am J Hypertens; 2007 Aug; 20(8):883. PubMed ID: 17679037 [No Abstract] [Full Text] [Related]
4. Hemostatic abnormalities associated with obesity and the metabolic syndrome. Reaven GM; Scott EM; Grant PJ; Lowe GD; Rumley A; Wannamethee SG; Stratmann B; Tschoepe D; Blann A; Juhan-Vague I; Alessi MC; Bailey C J Thromb Haemost; 2005 May; 3(5):1074-85. PubMed ID: 15869606 [No Abstract] [Full Text] [Related]
5. Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension. Litwin M; Sladowska J; Antoniewicz J; Niemirska A; Wierzbicka A; Daszkowska J; Wawer ZT; Janas R; Grenda R Am J Hypertens; 2007 Aug; 20(8):875-82. PubMed ID: 17679036 [TBL] [Abstract][Full Text] [Related]
6. [Correction of thrombocyte-vascular hemostasis in metabolic syndrome]. Medvedev IN; Gromnatskiĭ NI; Volobuev IV; Osipova VM; Storozhenko MV Klin Med (Mosk); 2006; 84(1):46-9. PubMed ID: 16512397 [TBL] [Abstract][Full Text] [Related]
7. [Dynamics of primary hemostasis activity in patients with arterial hypertension and metabolic syndrome treated with candesartan]. Simonenko VB; Medvedev IN; Tolmachev VV Klin Med (Mosk); 2011; 89(3):35-8. PubMed ID: 21861401 [TBL] [Abstract][Full Text] [Related]
8. [Metabolic syndrome and risk factors for developing arterial hypertensia]. Georgian Med News; 2010; (184-185):27-33. PubMed ID: 20834072 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenetic aspects of hypertension in case of metabolic syndrome]. Simonenko VB; Medvedev IN; Kumova TA Voen Med Zh; 2010 Sep; 331(9):41-4. PubMed ID: 21254528 [TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome]. Rovda IuI; Kazakova LM; Rovda TS; Rovda EIu Ter Arkh; 2004; 76(11):35-40. PubMed ID: 15658535 [TBL] [Abstract][Full Text] [Related]
11. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891 [TBL] [Abstract][Full Text] [Related]
12. [The role of insulin resistance in pathogenesis of arterial hypertension]. Simonenko VB; Goriutskii VN; Dulin PA Klin Med (Mosk); 2014; 92(9):27-33. PubMed ID: 25790708 [TBL] [Abstract][Full Text] [Related]
13. [Structure of risk factors, damages of target organs, and metabolic changes in patients with arterial hypertension of various age groups]. Boĭtsov SA; Urinskiĭ AM; Kuznetsov RL; Pozdniakov IuM Kardiologiia; 2009; 49(4):19-24. PubMed ID: 19463113 [TBL] [Abstract][Full Text] [Related]
14. [Metabolic syndrome: more questions than answers]. Chibisov SM; Rapoport SI; Kolesnikov DB; Loboda AIu Klin Med (Mosk); 2008; 86(6):30-5. PubMed ID: 18720708 [TBL] [Abstract][Full Text] [Related]
15. [Hemorheology and hemostasis in patients suffering from ischemic cerebral stroke and metabolic syndrome]. Orlov SV; Domashenko MA; Kostyreva MV; Shabalina AA; Ionova VG; Tanashian MM Klin Med (Mosk); 2007; 85(1):40-4. PubMed ID: 17419354 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach. Ganne S; Arora S; Karam J; McFarlane SI Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665 [TBL] [Abstract][Full Text] [Related]
17. [Dysmetabolic symptomatic arterial hypertension and dysmetabolic disease]. Bokarev IN; Shubina OI Klin Med (Mosk); 2009; 87(8):67-71. PubMed ID: 19827536 [No Abstract] [Full Text] [Related]
18. [Metabolic profile of patients with cholesterol gallstone disease]. Cojocaru C; Pandele GI Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):677-82. PubMed ID: 21243792 [TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Lender D; Sysko SK Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782 [TBL] [Abstract][Full Text] [Related]
20. [Peculiarities of cardiovascular and metabolic disturbances in women after ovariectomy]. Skibitskĭ VV; Medvedeva IuN; Shukhardina EL; Skibitskaia SV Kardiologiia; 2007; 47(10):63-7. PubMed ID: 18260947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]